Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease. [PDF]
Cordido A +2 more
europepmc +1 more source
Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease. [PDF]
Fleischer LT +7 more
europepmc +1 more source
Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease. [PDF]
Russell LG +11 more
europepmc +1 more source
Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model.
Yanda MK, Zeidan A, Cebotaru L.
europepmc +1 more source
Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease. [PDF]
Yanda MK, Tomar V, Cebotaru L.
europepmc +1 more source
Perspectives on Drug Development in Autosomal Recessive Polycystic Kidney Disease.
Liebau MC, Hartung EA, Perrone RD.
europepmc +1 more source
The Enigma of Clinical Heterogeneity Among Autosomal Recessive Polycystic Kidney Disease Siblings: PKHD1 Genotype Versus Other Genomic or Environmental Modifier. [PDF]
Meena P, Hopp K.
europepmc +1 more source
Autosomal Recessive Polycystic Kidney Disease and Epidemiologic Factors
Parsa Yousefichaijan +2 more
openalex +1 more source
Prostatic cyst in autosomal recessive polycystic kidney disease: A case presentation and literature review. [PDF]
Bai K, Lynch NB, Carpenter CP.
europepmc +1 more source

